SIGA
Interim Results From Stomp Study of SIGA’s Tecovirimat in Treatment of Mpox Announced
时间：2024-12-11 05:00:43 市场： 美股 综合
SIGA Technologies Inc - Study Stopped Enrolling Patients in All Study Arms
时间：2024-12-11 05:00:43 市场： 美股 综合
Nih: Nih Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain - Website
时间：2024-12-11 04:16:50 市场： 综合 美股
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024
时间：2024-11-08 05:05:11 市场： 美股 综合
SIGA Enters Into Exclusive License Agreement With Vanderbilt University for Novel Poxvirus Monoclonal Antibodies
时间：2024-10-22 19:30:00 市场： 美股 综合